| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3899439 | Urology | 2014 | 6 Pages |
Abstract
The cavernous injection of avanafil in T2DM rats resulted in partial improvement in erectile responses. These findings suggest that intracavernosal administration of avanafil might be beneficial for the treatment of erectile dysfunction in patients with T2DM.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Didem Yilmaz, Nur Bayatli, Ozge Un, Philip J. Kadowitz, Suresh C. Sikka, Serap Gur,